News

Novartis Pluvicto shows survival benefit in prostate cancer patients in phase 3 trial

View more

Dec 07, 2022

3D printing can help produce valuable radiopharmaceuticals

View more

Dec 07, 2022

PET may aid decision-making in heart disease cases

View more

Dec 05, 2022

Radium chelator researchers working to improve targeted cancer therapies

View more

Dec 05, 2022

Triplet therapy incorporating novel PSMA-TRT ²²⁵Ac-J591 shows efficacy in mCRPC

View more

Dec 05, 2022

POINT Biopharma Releases New Preclinical Data Supporting the Combination of ¹⁷⁷Lu-PNT6555 with Immunotherapy

View more

Dec 05, 2022